Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-001279
Filing Date
2025-07-23
Accepted
2025-07-23 14:26:36
Documents
36
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acbm_10q.htm   iXBRL 10-Q 434755
2 CERTIFICATION acbm_ex311.htm EX-31.1 9673
3 CERTIFICATION acbm_ex321.htm EX-32.1 4052
  Complete submission text file 0001640334-25-001279.txt   1704117

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acbm-20240630.xsd EX-101.SCH 16616
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acbm-20240630_lab.xml EX-101.LAB 110174
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acbm-20240630_cal.xml EX-101.CAL 23683
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acbm-20240630_pre.xml EX-101.PRE 82018
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acbm-20240630_def.xml EX-101.DEF 24502
39 EXTRACTED XBRL INSTANCE DOCUMENT acbm_10q_htm.xml XML 149546
Mailing Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038
Business Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038 (317) 286-6788
ACRO BIOMEDICAL CO., LTD. (Filer) CIK: 0001622996 (see all company filings)

EIN.: 471950356 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55643 | Film No.: 251142736
SIC: 7900 Services-Amusement & Recreation Services
(CF Office: 07 Trade & Services)